These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6132168)

  • 1. Ketoacidosis resulting from precipitation of insulin in syringe used to deliver constant subcutaneous insulin infusion.
    Freeman DJ; Wolfe BM; Mascarenhas M
    Lancet; 1983 Apr; 1(8328):828. PubMed ID: 6132168
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump.
    Knight G; Jennings AM; Boulton AJ; Tomlinson S; Ward JD
    Br Med J (Clin Res Ed); 1985 Aug; 291(6492):371-2. PubMed ID: 3926198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ketoacidosis without hyperglycemia in a diabetic patient treated with the portable insulin infusion pump].
    Vialettes B; Lassmann V; Pfister B; Vague P
    Presse Med; 1985 Jul; 14(27):1474. PubMed ID: 3161066
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

  • 5. Complications of insulin infusion pump therapy.
    Bending JJ; Pickup JC
    JAMA; 1985 May; 253(18):2644-5. PubMed ID: 3989940
    [No Abstract]   [Full Text] [Related]  

  • 6. [Continuous subcutaneous insulin infusion].
    Ito H; Kanatsuka A
    Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of insulin pump therapy with raised serum amyloid A in type I diabetes mellitus.
    Brownlee M; Vlassara H; Cerami A; Martin TR; Li JJ; McAdam KP
    Lancet; 1984 Feb; 1(8374):411-3. PubMed ID: 6142148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of a portable infusion pump and pen-type injector in type 1 diabetes mellitus.
    Tsuchiya Y; Cho H; Kotoh S; Yokoyama T; Matsuo N
    Acta Paediatr Jpn; 1987 Jun; 29(3):361-7. PubMed ID: 3144863
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of brittle diabetes.
    Gill GV; Alberti KG
    BMJ; 1991 Aug; 303(6797):285-6. PubMed ID: 1888928
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of ketosis during intensive insulin therapy in pre-school-age diabetic children.
    Brambilla P; Artavia-Loria E; Chaussain JL; Bougneres PF
    Diabetes Care; 1987; 10(1):44-8. PubMed ID: 3105985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic ketoacidosis associated with outpatient treatment using continuous subcutaneous insulin infusion.
    Boulton AJ; Knight G; Drury J; Ward JD
    Postgrad Med J; 1983 Jul; 59(693):438-9. PubMed ID: 6413960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia.
    Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous subcutaneous insulin infusion].
    Araki H; Makino H; Yoshida S
    Nihon Rinsho; 1990 Dec; 48 Suppl():1038-43. PubMed ID: 2086865
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of flocculated human insulin in jet infusion devices.
    Lindsay R
    Diabetes Care; 1989 Jan; 12(1):42-3. PubMed ID: 2496964
    [No Abstract]   [Full Text] [Related]  

  • 15. [Unstable type I diabetes mellitus: comparative study between intensive conventional treatment and continuous subcutaneous infusion of insulin].
    Levy I; Bergua M; Esmatjes E; Halperin I; Figuerola D
    Med Clin (Barc); 1984 Oct; 83(13):525-8. PubMed ID: 6392766
    [No Abstract]   [Full Text] [Related]  

  • 16. American Diabetes Association Resource Guide 2003. Insulin delivery.
    Diabetes Forecast; 2003 Jan; 56(1):59-61, 63-6, 68-71, 74-6. PubMed ID: 14765409
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetic ketoacidosis caused by exposure of insulin to low temperature.
    Minuto N; Tambroni B; Vannati M; Emmanuele V; Russo C; Lorini R; d'Annunzio G
    Diabetes Technol Ther; 2010 Sep; 12(9):745-6. PubMed ID: 20687866
    [No Abstract]   [Full Text] [Related]  

  • 18. New technologies and old challenges in type 1 diabetes.
    Rodriguez H
    Diabetes Technol Ther; 2012 Dec; 14(12):1082-3. PubMed ID: 23216337
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis].
    Gubrianska D; Moberg E; Palmér M
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1967-8. PubMed ID: 19764373
    [No Abstract]   [Full Text] [Related]  

  • 20. CSII and ICT in treating Type I diabetic individuals.
    Georgopoulos A
    Diabetes Care; 1983; 6(2):201-1. PubMed ID: 6343026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.